BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9477208)

  • 1. Metabolic syndrome' in a middle-aged Finnish population.
    Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Takala JK
    J Cardiovasc Risk; 1997 Aug; 4(4):291-5. PubMed ID: 9477208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin resistance and metabolic syndrome in first-degree relatives of patients with NIDDM].
    Camps I; Biarnés J; Fernández-Real JM; Insa R; Soler J; Fernández Castañer M
    Med Clin (Barc); 1999 Mar; 112(8):281-4. PubMed ID: 10207842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.
    Balkau B; Sapinho D; Petrella A; Mhamdi L; Cailleau M; Arondel D; Charles MA;
    Eur J Clin Nutr; 2006 Mar; 60(3):295-304. PubMed ID: 16278693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity type and clustering of insulin resistance-associated cardiovascular risk factors in middle-aged men and women.
    Vanhala MJ; Pitkäjärvi TK; Kumpusalo EA; Takala JK
    Int J Obes Relat Metab Disord; 1998 Apr; 22(4):369-74. PubMed ID: 9578244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinsulinaemia in hypertensive subjects: validity of a test for the detection of insulin resistance in clinical practice.
    Vanhala MJ; Pitkäjärvi TK; Keinänen-Kiukaanniemi SM; Kumpusalo EA; Takala JK
    J Hum Hypertens; 1998 Jul; 12(7):463-7. PubMed ID: 9702932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome.
    Mardarowicz G; Lopatyński J; Nicer T
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):426-31. PubMed ID: 15315027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
    Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
    Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome in an Indian urban population.
    Gupta R; Deedwania PC; Gupta A; Rastogi S; Panwar RB; Kothari K
    Int J Cardiol; 2004 Nov; 97(2):257-61. PubMed ID: 15458693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population.
    Kanauchi M; Kanauchi K; Hashimoto T; Saito Y
    Curr Med Res Opin; 2004 Sep; 20(9):1365-70. PubMed ID: 15383184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of insulin resistance in essential hypertension.
    Lind L; Berne C; Lithell H
    J Hypertens; 1995 Dec; 13(12 Pt 1):1457-62. PubMed ID: 8866908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
    Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
    Diabetes; 1990 Nov; 39(11):1430-5. PubMed ID: 2227116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service.
    Tähtinen TM; Vanhala MJ; Oikarinen JA; Keinänen-Kiukaanniemi SM
    J Cardiovasc Risk; 1998; 5(5-6):319-23. PubMed ID: 9920003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.
    Gupta R; Sarna M; Thanvi J; Rastogi P; Kaul V; Gupta VP
    Indian Heart J; 2004; 56(6):646-52. PubMed ID: 15751521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
    Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
    Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
    Santos AC; Lopes C; Guimarães JT; Barros H
    Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.